| Next 10 |
Search for News Releases and Articles
Search Results for "Accesswire Ia"
-
LOS ANGELES, CA / ACCESSWIRE / May 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Healthcare Services Group, Inc. (''Healthcare Services'' or ''the Company'') (NASDAQ: HCSG ) for violation...
-
LOS ANGELES, CA / ACCESSWIRE / May 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mobile TeleSystems PJSC (''Mobile TeleSystems'' or ''the Company'') (NYSE: MBT ) for violations of §§10(b) an...
-
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, toda...
-
CEDARHURST, NY / ACCESSWIRE /, May 19, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encou...
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MBT, ARA and FSNN
NEW YORK, NY / ACCESSWIRE / May 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff...
-
CARLSBAD, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been valued ...
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MBT, ARA and FSNNNEW YORK, NY / ACCESSWIRE / May 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff...
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HCSG, BV and MOMONEW YORK, NY / ACCESSWIRE / May 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff...
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HCSG, BV and MOMONEW YORK, NY / ACCESSWIRE / May 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff...
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HCSG, BV and MOMO
NEW YORK, NY / ACCESSWIRE / May 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff...
Is ( accesswire-ia ) Trending?
Find more about ( accesswire-ia )
Write an Article on ( accesswire-ia )
Join the ( accesswire-ia ) Discussion
Trending News
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, toda...
